Better-than-expected quarterly results at Johnson & Johnson

Johnson & Johnson published better-than-expected quarterly results last yesterday, thanks to its increased revenues derived from prescription drugs and medical devices.

According to the flash report of the American health-cosmetic company in the last quarter of 2012, the company achieved  2.6 billion USD profits, 91 cents per share. In the same period of 2011, the company generated a profit of 218 million USD, 8 cents per share. (Questor, tozsdeforum.hu)